Phase II study of tiazofurin in colorectal cancer: a National Cancer Institute of Canada Study.
Maroun
J A
JA
Ontario Cancer Treatment and Research Foundation, University of Ottawa, Faculty of Health Sciences, Canada.
Eisenhauer
E
E
Cripps
C
C
Maksymiuk
A
A
D000328:Adult; D000368:Aged; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*; D012254:Ribavirin / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*
D012263:Ribonucleosides; D012254:Ribavirin; C033706:tiazofurin